396 related articles for article (PubMed ID: 25689357)
1. Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis.
Liu XY; Li HL; Su JB; Ding FH; Zhao JJ; Chai F; Li YX; Cui SC; Sun FY; Wu ZY; Xu P; Chen XH
J Neurochem; 2015 Apr; 133(2):187-98. PubMed ID: 25689357
[TBL] [Abstract][Full Text] [Related]
2. Regulation of alternative splicing of the receptor for advanced glycation endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear ribonucleoprotein H.
Ohe K; Watanabe T; Harada S; Munesue S; Yamamoto Y; Yonekura H; Yamamoto H
J Biochem; 2010 May; 147(5):651-9. PubMed ID: 20028692
[TBL] [Abstract][Full Text] [Related]
3. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
Kashima T; Rao N; David CJ; Manley JL
Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
[TBL] [Abstract][Full Text] [Related]
4. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
[TBL] [Abstract][Full Text] [Related]
5. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
[TBL] [Abstract][Full Text] [Related]
6. Lower expression level of two RAGE alternative splicing isoforms in Alzheimer's disease.
Zhu H; Ding Q
Neurosci Lett; 2015 Jun; 597():66-70. PubMed ID: 25912778
[TBL] [Abstract][Full Text] [Related]
7. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
8. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.
Nozaki I; Watanabe T; Kawaguchi M; Akatsu H; Tsuneyama K; Yamamoto Y; Ohe K; Yonekura H; Yamada M; Yamamoto H
Arch Histol Cytol; 2007 Dec; 70(5):279-90. PubMed ID: 18431028
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
11. hnRNP L and hnRNP A1 induce extended U1 snRNA interactions with an exon to repress spliceosome assembly.
Chiou NT; Shankarling G; Lynch KW
Mol Cell; 2013 Mar; 49(5):972-82. PubMed ID: 23394998
[TBL] [Abstract][Full Text] [Related]
12. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
[TBL] [Abstract][Full Text] [Related]
13. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.
Jean-Philippe J; Paz S; Lu ML; Caputi M
Biochim Biophys Acta; 2014; 1839(4):251-8. PubMed ID: 24530421
[TBL] [Abstract][Full Text] [Related]
14. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
Damgaard CK; Tange TO; Kjems J
RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
[TBL] [Abstract][Full Text] [Related]
15. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.
Mayeda A; Krainer AR
Cell; 1992 Jan; 68(2):365-75. PubMed ID: 1531115
[TBL] [Abstract][Full Text] [Related]
16. Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation.
Hamilton BJ; Burns CM; Nichols RC; Rigby WF
J Biol Chem; 1997 Nov; 272(45):28732-41. PubMed ID: 9353343
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
[TBL] [Abstract][Full Text] [Related]
18. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
Cáceres JF; Stamm S; Helfman DM; Krainer AR
Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
[TBL] [Abstract][Full Text] [Related]
19. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation.
van der Houven van Oordt W; Diaz-Meco MT; Lozano J; Krainer AR; Moscat J; Cáceres JF
J Cell Biol; 2000 Apr; 149(2):307-16. PubMed ID: 10769024
[TBL] [Abstract][Full Text] [Related]
20. hnRNP A1 and secondary structure coordinate alternative splicing of Mag.
Zearfoss NR; Johnson ES; Ryder SP
RNA; 2013 Jul; 19(7):948-57. PubMed ID: 23704325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
